Alaunos Therapeutics reported $1.52M in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Alaunos Therapeutics USD 1.52M 367K Jun/2026
Amgen USD 96.05B 409M Sep/2026
AstraZeneca USD 119.92B 4.09B Sep/2026
Baxter International USD 19.41B 377M Sep/2026
Biogen USD 32.05B 32.5M Sep/2026
Bioline Rx USD 33.48M 5.32M Jun/2026
Bristol-Myers Squibb USD 88.77B 1.14B Sep/2026
Celltrion KRW 779.18B 10.37B Jun/2026
Corcept Therapeutics USD 1.03B 145.32M Sep/2026
Cspc Pharmaceutical CNY 46.7B 695.56M Dec/2025
Curis USD 29.69M 9.72M Mar/2026
Deva Holding AS TRY 12.93B 1.83B Sep/2023
Dianthus Therapeutics USD 1.28B 62.98M Sep/2026
Divis Laboratories Ltd INR 219.64B 19.31B Sep/2026
Gilead Sciences USD 51.41B 2.05B Sep/2026
GlaxoSmithKline GBP 71.7B 9.96B Sep/2026
Incyte USD 7.29B 585.39M Sep/2026
Intrexon USD 73.16M 77.88M Jun/2024
Ionis Pharmaceuticals USD 2.91B 81.91M Sep/2026
J&J USD 197.42B 3.64B Sep/2026
Kangmei Pharma CNY 13.07B 239.31M Jun/2026
Karyopharm Therapeutics USD 131.42M 23M Mar/2026
Knight Therapeutics CAD 1.05B 2.28M Dec/2025
Laboratorios Farma EUR 799.88M 99.95M Dec/2023
Malin Corporation EUR 198.5M 70.1M Dec/2024
Medical Developments International AUD 63.57M 2.83M Dec/2025
Merck USD 132.77B 2.97B Sep/2026
Neuren Pharmaceuticals AUD 342.86M 11.61M Dec/2025
Novartis USD 117.15B 4.88B Sep/2026
Organigram Holdings CAD 820.26M 298.95M Jun/2026
Ovoca Bio EUR 2.07M 414K Dec/2025
Pfizer USD 204.54B 3.41B Sep/2026
Pharma Mar EUR 408.4M 14.8M Sep/2026
PTC Therapeutics USD 3.21B 42.76M Sep/2026
Qiagen NV USD 5.89B 107.14M Jun/2026
Regeneron Pharmaceuticals USD 44.41B 2.67B Sep/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Sangamo BioSciences USD 97.56M 11.39M Jun/2025
Sartorius EUR 9.67B 70.9M Sep/2026
Sino Biopharmaceutical CNY 74.89B 9.49B Jun/2025
TG Therapeutics USD 1.59B 47.38M Sep/2026
Tilray USD 2.1B 15.95M Sep/2025
Verastem USD 227.81M 18.63M Mar/2026
Zealand Pharma A/S 15.3B 647.8M Mar/2026
Zz Pientze Pharmaceu CNY 17.71B 799.05M Sep/2026